<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-14T02:46:29Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:2072/485383" metadataPrefix="qdc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:2072/485383</identifier><datestamp>2025-10-27T13:36:30Z</datestamp><setSpec>com_2072_98</setSpec><setSpec>col_2072_378192</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Transcriptomic analysis of allergic patch test reactions in non-atopic patients: a comparative study across multiple allergens</dc:title>
   <dc:creator>Pesqué, David</dc:creator>
   <dc:creator>Andrades, Evelyn</dc:creator>
   <dc:creator>Berenguer-Molins, Pau</dc:creator>
   <dc:creator>Perera-Bel, Júlia</dc:creator>
   <dc:creator>Clarós, Miquel</dc:creator>
   <dc:creator>Bódalo-Torruella, Marta</dc:creator>
   <dc:creator>Gonzàlez-Farré, Mònica</dc:creator>
   <dc:creator>Gallardo, Fernando</dc:creator>
   <dc:creator>Pujol Vallverdú, Ramón M.</dc:creator>
   <dc:creator>Giménez-Arnau, Ana M</dc:creator>
   <dc:subject>Contact dermatitis</dc:subject>
   <dc:subject>Allergic</dc:subject>
   <dc:subject>Transcriptomic</dc:subject>
   <dc:subject>Immune</dc:subject>
   <dc:subject>Patch test</dc:subject>
   <dcterms:abstract>Altres ajuts: acords transformatius de la UAB</dcterms:abstract>
   <dcterms:abstract>Altres ajuts: LEO Foundation (LF-OC-23-001209)</dcterms:abstract>
   <dcterms:abstract>Background: Immune mechanisms underlying elicitation in allergic contact dermatitis (ACD) have yet to be fully elucidated. Previous studies have shown a double-faceted nature of ACD with both common biomarkers among different allergens and allergen73 specific imprinting, albeit with discordance in terms of relevant pathways involved. Several factors, including co-existing atopic dermatitis, may influence immune reactions. We aim to characterize molecular signatures and their immune mechanisms of different relevant allergens (nickel, 2-hydroxyethylmethacrylate [2-HEMA], methylisothiazolinone [MIT], formaldehyde) in strong and extreme positive (2/3+) patch test reactions of patients without atopic dermatitis. Methods: A transcriptomic analysis of 40 skin biopsies of ACD reactions (11 nickel, 10 MIT, 10 2-HEMA, 9 formaldehyde) and 19 controls (petrolatum-occluded skin) was performed using RNA sequencing. Differentially-expressed genes (DEG) were assessed and enriched functional pathways were obtained with an over-representation analysis for allergens. Results: ACD molecular profiling revealed a strong, common imprinting of DEG among allergens versus controls (n=814), with further partially-shared DEG among allergens (n=664) and allergen-specific DEG (n=430). The most relevant shared pathways were associated with immune adaptive and innate responses. All allergens exhibited mixed effector immune responses, mainly type 1 and 3 immunity, and, to a lesser extent, type 2 immunity. Furthermore, partially-shared and unique DEG were associated with further inflammatory pathways, particularly for nickel and 2-HEMA. Conclusions: This study confirms shared ACD imprinting among different allergens and shared pathways' predominant role in ACD elicitation in patients without atopic dermatitis, alongside allergen-specific immune processes and mixed effector responses (type 1, 3 and 2).</dcterms:abstract>
   <dcterms:issued>2025</dcterms:issued>
   <dc:type>Article</dc:type>
   <dc:relation>Allergy ; 2025</dc:relation>
   <dc:rights>open access</dc:rights>
   <dc:rights>Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original.</dc:rights>
   <dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights>
   <dc:publisher/>
</qdc:qualifieddc></metadata></record></GetRecord></OAI-PMH>